Zobrazeno 1 - 10
of 263
pro vyhledávání: '"B Hoogstraten"'
Autor:
R K, Oldham, J, Stark, N M, Barth, B, Hoogstraten, C H, Brown, T, O'Connor, S, Dupere, R, Birch
Publikováno v:
Molecular biotherapy. 3(2)
We have evaluated the effect of Interleukin-2 [IL-2] after Cyclophosphamide (C) chemotherapy in 41 patients with metastatic cancer. IL-2 was given as a continuous infusion priming cycle 36 hours after C at 1 gm/m2 intravenously. In 39 evaluable patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::328e7f56ca6286184f55d25af45c678e
https://pubmed.ncbi.nlm.nih.gov/1910623
https://pubmed.ncbi.nlm.nih.gov/1910623
Autor:
A. Kennedy, B. Hoogstraten, Clarence B. Vaughn, Tranum Bl, Henry E. Wilson, W. G. Tucker, Frank E. Smith, John H. Costanzi, Tate Thigpen, T. R. Maloney, Bohumil A. Samal, Robert L. Palmer, Saul E. Rivkin
Publikováno v:
Cancer. 41:2078-2083
Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1, plus 5-FU day 1 and 8, and cyclophosphamide day 1 (AFC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ac3cb4aa9ff298853f742e04b1a6098
https://doi.org/10.1002/1097-0142(197806)41:6<2078::aid-cncr2820410602>3.0.co
https://doi.org/10.1002/1097-0142(197806)41:6<2078::aid-cncr2820410602>3.0.co
Publikováno v:
Cancer. 47:207-214
On the initiative of the World Health Organization, two meetings on the Standardization of Reporting Results of Cancer Treatment have been held with representatives and members of several organizations. Recommendations have been developed for standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94a744a84ce1590c716813cea433ed34
https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co
https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co
Autor:
J. Whitecar, John J. Costanzi, Teresa J. Vietti, W. J. Stuckey, James S. Hewlett, John H. Saiki, Francis S. Morrison, B. Hoogstraten, Kenneth B. McCredie
Publikováno v:
Cancer. 42:2111-2114
101 patients with acute leukemia in relapse were treated with 5-azacytidine according to three schedules: Regimen A--300 mg/m2(day divided intravenously at 8 hour intervals for 5 days; Regimen B--750 mg/m2 as a single iv pulse dose administered at 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f6e4429f7bad275d69aa14e6dfc17c7
https://doi.org/10.1002/1097-0142(197811)42:5<2111::aid-cncr2820420505>3.0.co
https://doi.org/10.1002/1097-0142(197811)42:5<2111::aid-cncr2820420505>3.0.co
Autor:
Simon Kramer, B. Hoogstraten, James F. Holland, Leon Stutzman, Harry J. Perlberg, Nis I. Nissen, Oliver Glidewell, Johannes Blom
Publikováno v:
Cancer. 43:1234-1244
The Cancer and Acute Leukemia Group B studied the effect of combination chemotherapy-radiotherapy on Stage III Hodgkin's disease. Chemotherapy consisting of 4 weekly doses of vinblastine and one dose of mechlorethamine hydrochloride was followed by n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fda7d41f1f6ca41be621538d1719264
https://doi.org/10.1002/1097-0142(197904)43:4<1234::aid-cncr2820430411>3.0.co
https://doi.org/10.1002/1097-0142(197904)43:4<1234::aid-cncr2820430411>3.0.co
Autor:
Robert M. O'Bryan, Tate Thigpen, P. N. Kim, Charles A. Coltman, R. Bottomley, John D. Bonnet, Joseph D. McCracken, Carl Groppe, Frank Panettiere, Vainutis K. Vaitkevicius, Buroker T, B. Hoogstraten, Henry E. Wilson, Lance K. Heilbrun
Publikováno v:
Cancer. 42:1228-1233
The Southwest Oncology Group (SWOG) in a randomized trial evaluated 5FU infusions in combination with either Mitomycin-C or Methyl-CCNU in patients with disseminated large bowel cancer. A response rate of 18% was noted on the 5FU-Mitomycin limb as co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de062e0751164d57bdbe99b1c316a36b
https://doi.org/10.1002/1097-0142(197809)42:3<1228::aid-cncr2820420330>3.0.co
https://doi.org/10.1002/1097-0142(197809)42:3<1228::aid-cncr2820420330>3.0.co
Autor:
Charles D. Haas, Tribhawan S. Vats, Teresa J. Vietti, B. Hoogstraten, Diane M. Komp, Dell A. Shepherd
Publikováno v:
Medical and Pediatric Oncology. 8:243-250
Twenty-one children (19 with leukemia) were given 34 courses of vindesine on a weekly or twice-weekly schedule in escalating doses. Thirty-three courses were fully or partially evaluable for response and/or toxicity. Granulocyto-penia was the dose-li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::207a4599b735b5747b8886913c0ae3f1
https://doi.org/10.1002/mpo.2950080306
https://doi.org/10.1002/mpo.2950080306
Autor:
Tate Thigpen, J. J. Costanzi, John D. Bonnet, B. Hoogstraten, Stephen L. George, H. Braine, Bohumil A. Samal, Saul E. Rivkin
Publikováno v:
Cancer. 38:13-20
In January, 1972, the Southwest Oncology Group initiated two randomized studies for patients with advanced breast cancer. The study for patients with prior chemotherapy showed a 33% response rate with adriamycin. The study for patients without previo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a0324d7cf4e376679557e7dfc2d2f41
https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co
https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co
Publikováno v:
Blood. 55:595-601
An in vitro test system to quantitatively assess the chemotherapy sensitivity of human acute leukemic colony-forming cells (L-CFU) in relation to normal granulocytic precursor cells (CFU-C) has been developed. After simultaneous exposure of leukemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71aede8c5e2cd39957c037743df7a67a
https://doi.org/10.1182/blood.v55.4.595.bloodjournal554595
https://doi.org/10.1182/blood.v55.4.595.bloodjournal554595
Autor:
B. Hoogstraten, Vainutis K. Vaitkevicius, John J. Costanzi, Fred C. Delaney, Joseph M. Quagliana, Charles A. Coltman
Publikováno v:
Cancer. 35:342-346
BCNU, hydroxyurea, and imidazole carboxamide (DTIC) were administered to 89 patients with disseminated malignant melanoma. A response rate of 27% was observed. The addition of vincristine in another 89 patients did not significantly improve the respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c5c5a3dec6552fceda82a51383fa645
https://doi.org/10.1002/1097-0142(197502)35:2<342::aid-cncr2820350207>3.0.co
https://doi.org/10.1002/1097-0142(197502)35:2<342::aid-cncr2820350207>3.0.co